. 2020 Oct 14;31(12):3077–3085. doi: 10.1111/jce.14770

Table 5.

Association of atrial arrhythmias with 30‐day all‐cause mortality

Arrhythmia	Event rates based on arrhythmia (%)		Unadjusted OR (95% CI)	p Value	Adjusted OR (95% CI) ^a	p Value
Arrhythmia	Yes	No	Unadjusted OR (95% CI)	p Value	Adjusted OR (95% CI) ^a	p Value
Atrial fibrillation (AF)	37.7	12.8	4.12 (2.82–6.02)	<.001	2.16 (1.33–3.52)	.002
AFL	22.5	16.2	1.50 (0.70–3.22)	.293	0.65 (0.27–1.55)	.335
Any AF/AFL	35.5	12.9	3.74 (2.57–5.43)	<.001	1.93 (1.20–3.11)	.007
Newly detected AF/AFL	36.6	14.3	3.47 (2.23–5.41)	<.001	2.87 (1.74–4.74)	<.001

^{^a}

Adjusted for age, body mass index, race, coronary artery disease, congestive heart failure, prior stroke, prior AF, hypertension, lung disease, renal disease, active cancer, immunosuppression, angiotensin converting enzyme inhibitor or angiotensin receptor blocker use, nonsteroidal inflammatory use, proton pump inhibitor use, statin use or hypoxia on presentation based on presence of univariate significance (p < .10).

Abbreviations: AFL, atrial flutter/tachycardia; CI, confidence interval; OR, odds ratio.